logo oncology-news

Онкология  >  Новости онкологии

При финансовой поддержке logo MSD Oncology

In right-sided colon cancer, BRAF may be key

BRAF mutation status may be key factor in treatment response; chemo plus anti-EGFR should not necessarily be excluded for first-line treatment.